Hypertension severity is associated with impaired cognitive performance

Journal of the American Heart Association

Volumn 6, Issue 1, 2017, Pages

  Muela, Henrique C S ^a,c   Costa Hong, Valeria A ^a   Yassuda, Mônica S ^b   Moraes, Natália C ^b   Memória, Claudia M ^b   Machado, Michel F ^b   Macedo, Thiago A ^a   Shu, Edson B S ^b   Massaro, Ayrton R ^b   Nitrini, Ricardo ^b   Mansur, Alfredo J ^a   Bortolotto, Luiz A ^a  

^a Heart Institute (Incor)   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Universidade Agostinho Neto   (Angola)

Author keywords

Cognition; Cognitive impairment; High blood pressure; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPTH PERCEPTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; LANGUAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; RESPONSE TIME; AGED; BRAZIL; CASE CONTROL STUDY; COGNITIVE DEFECT; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BRAZIL; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 85009961963     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.004579     Document Type: Article

References (57)

1. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, McAlister FA, Johansen H, Baclic O, Campbell N. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3:e003423.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
3. Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, dagnosis, and treatment. Clin Geriatr Med. 2014;30:421-442.
4. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63-75.e2.
5. Chaves ML, Camozzato AL, Godinho C, Piazenski I, Kaye J. Incidence of mild cognitive impairment and Alzheimer disease in Southern Brazil. J Geriatr Psychiatry Neurol. 2009;22:181-187.
6. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
7. Bischkopf J, Busse A, Angermeyer MC. Mild cognitive impairment-a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand. 2002;106:403-414.
8. Tsivgoulis G, Alexandrov AV, Wadley VG, Unverzagt FW, Go RC, Moy CS, Kissela B, Howard G. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology. 2009;73:589-595.
9. Fratiglioni L, De Ronchi D, Agüero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15:365-375.
10. Kuo HK, Sorond F, Iloputaife I, Gagnon M, Milberg W, Lipsitz LA. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci. 2004;59:1191-1194.
11. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274:1846-1851.
12. Guo Z, Fratiglioni L, Winblad B, Viitanen M. Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol. 1997;145:1106-1113.
13. Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension. 2005;45:374-379.
14. Farmer ME, White LR, Abbott RD, Kittner SJ, Kaplan E, Wolz MM, Brody JA, Wolf PA. Blood pressure and cognitive performance. The Framingham Study. Am J Epidemiol. 1987;126:1103-1114.
15. Farmer ME, Kittner SJ, Abbott RD, Wolz MM, Wolf PA, White LR. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol. 1990;43:475-480.
16. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
17. Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension. 2000;36:1079-1082.
18. Kalra L, Jackson SH, Swift CG. Effect of antihypertensive treatment on psychomotor performance in the elderly. J Hum Hypertens. 1993;7:285-290.
19. Antelmi I, Chuang EY, Grupi CJ, Latorre Mdo R, Mansur AJ. Heart rate recovery after treadmill electrocardiographic exercise stress test and 24-hour heart rate variability in healthy individuals. Arq Bras Cardiol. 2008;90:380-385.
20. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertens~ao, Sociedade Brasileira de Nefrologia. VI Brazilian guidelines on hypertension. Arq Bras Cardiol. 2010;95:1-51.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
22. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr. 2003;61:777-781.
23. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummimgs JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
24. Memória CM, Yassuda MS, Nakano EY, Forlenza OV. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal Cognitive Assessment. Int J Geriatr Psychiatry. 2013;28:34-40.
25. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241.
26. Frota NAF, Nitrini R. Criteria for the diagnosis of Alzheimer's disease recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Group. 2011;5:146-152.
27. Miotto EC, Sato J, Lucia MCS, Camargo CHP, ScaffM. Development of an adapted version of the Boston Naming Test for Portuguese speakers. Rev Bras Psiquiatr. 2010;32:279-282.
28. Rosen WG. Verbal fluency in aging and dementia. J Clin Neuropsychol. 1980;2:135-146.
29. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. New York, NY: Oxford University Press; 2006:655-677.
30. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14:167-177.
31. Malloy-Diniz LF, Lasmar VAP, Gazinelli Lde SR, Fuentes D, Salgado JV. The Rey Auditory-Verbal Learning Test: applicability for the Brazilian elderly population. Rev Bras Psiquiatr. 2007;29:324-329.
32. Shin M-S, Park S-Y, Park S-R, Seol S-H, Kwon JS. Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test. Nat Protoc. 2006;1:892-899.
33. Aprahamian I, Martinelli JE, Neri AL, Yassuda MS. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds. Int Psychogeriatr. 2010;22:64-71.
34. Axelrod BN. Administration duration for the Wechsler Adult Intelligence Scale-III and Wechsler Memory Scale-III. Arch Clin Neuropsychol. 2001;16:293-301.
35. Leung JLM, Lee GTH, Lam YH, Chan RCC, Wu JYM. The use of the Digit Span Test in screening for cognitive impairment in acute medical inpatients. Int Psychogeriatr. 2011;23:1569-1574.
36. Waldstein SR. The relation of hypertension to cognitive function. Curr Dir Psychol Sci. 2003;12:9-12.
37. Liu H, Gao S, Hall KS, Unverzagt FW, Lane KA, Callahan CM, Hendrie HC. Optimal blood pressure for cognitive function: findings from an elderly African-American cohort study. J Am Geriatr Soc. 2013;61:875-881.
38. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:959-962.
39. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138:353-364.
40. Zahodne LB, Glymour MM, Sparks C, Bontempo D, Dixon RA, MacDonald SW, Manly JJ. Education does not slow cognitive decline with aging: 12-year evidence from the Victoria Longitudinal Study. J Int Neuropsychol Soc. 2011;17:1039-1046.
41. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep. 2004;4:374-380.
42. Stern Y. Cognitive reserve. Neuropsychologia. 2009;47:2015-2028.
43. Evans DA, Hebert LE, Beckett LA, Scherr PA, Albert MS, Chown MJ, Pilgrim DM, Taylor JO. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol. 1997;54:1399-1405.
44. Prencipe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F. Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J Neurol Neurosurg Psychiatry. 1996;60:628-633.
45. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
46. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844-866.
47. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713.
48. Garrett KD, Browndyke JN, Whelihan W, Paul RH, DiCarlo M, Moser DJ, Cohen RA, Ott BR. The neuropsychological profile of vascular cognitive impairment-no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. Arch Clin Neuropsychol. 2004;19:745-757.
49. Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 1999;53:670-678.
50. Tierney MC, Black SE, Szalai JP, Snow WG, Fisher RH, Nadon G, Chui HC. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol. 2001;58:1654-1659.
51. Traykov L, Baudic S, Thibaudet MC, Rigaud AS, Smagghe A, Boller F. Neuropsychological deficit in early subcortical vascular dementia: comparison to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:26-32.
52. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162:2078-2085.
53. Buffon F, Porcher R, Hernandez K, Kurtz A, Pointeau S, Vahedi K, Bousser MG, Chabria H. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77:175-180.
54. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry. 2004;75:441-447.
55. Luis CA, Keegan AP, Mullan M. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry. 2009;24:197-201.
56. Ng A, Chew I, Narasimhalu K, Kandiah N. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore. Singapore Med J. 2013;54:616-619.
57. Carlson MDA, Morrison RS. Study design, precision, and validity in observational studies. J Palliat Med. 2009;12:77-82.